By rbj
Biofarm, one of the most important drug manufacturers in Romania, reports positive developments for the preliminary results of 2021: turnover of 239 million lei and a net profit of 60 million lei, up 11% compared to 2020. In...
GDPR | COOKIES: We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.